VR Adviser Boosts Stake in Savara Inc. with Addition of Over 1 Million Shares

VR Adviser hedge fund increasing investment position in Savara Inc. biotechnology stock chart with SVRA ticker

“Institutional investor VR Adviser significantly increased its position in Savara Inc. (NASDAQ: SVRA) by acquiring more than 1 million additional shares in the most recent quarter. This move elevates VR Adviser’s holdings to over 13.7 million shares, representing a substantial portion of the biotech’s outstanding shares and underscoring continued confidence in the company’s rare disease … Read more